Clinical trial
Clinical Study to Evaluate the Efficacy and Safety of Octagam 10% in Idiopathic…
NCT00426270 · Octapharma, Industry · Completed
Key facts
| NCT number | NCT00426270 |
|---|---|
| Title | Clinical Study to Evaluate the Efficacy and Safety of Octagam 10% in Idiopathic Thrombocytopenic Purpura in Adults |
| Official title | Clinical Study to Evaluate the Efficacy and Safety of Octagam® 10% in Idiopathic Thrombocytopenic Purpura in Adults |
| Lead sponsor | Octapharma, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Immune Thrombocytopenic Purpura |
| Intervention type | Drug |
| Interventions | Octagam 10% |
| Enrollment | 116 |
| Start date | Jun 1, 2006 |
| Primary completion | Sep 1, 2008 |
| Completion | Sep 1, 2008 |
| First posted | Jan 24, 2007 |
| Last update posted | Aug 1, 2014 |
| Countries | Austria |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: